Authors:
TAMURA T
BAGGOTT JE
JOHNSTON KE
LI QJ
ANTONY AC
Citation: T. Tamura et al., THE FORM OF FOLATE AFFECTS THE MECHANISMS OF METHOTREXATE RESISTANCE IN ENTEROCOCCUS-FAECIUM (VOL 143, PG 2639, 1997), Microbiology, 144, 1998, pp. 593-593
Citation: Je. Baggott et al., ORAL DOSE OF [6R]-5-FORMYLTETRAHYDROFOLATE (5-HCO-H4F) IS BIOACTIVE IN HUMANS, The FASEB journal, 12(4), 1998, pp. 3189-3189
Citation: Sl. Morgan et al., FOLIC-ACID SUPPLEMENTATION PREVENTS DEFICIENT BLOOD FOLATE LEVELS ANDHYPERHOMOCYSTEINEMIA DURING LONG-TERM, LOW-DOSE METHOTREXATE THERAPY FOR RHEUMATOID-ARTHRITIS - IMPLICATIONS FOR CARDIOVASCULAR-DISEASE PREVENTION, Journal of rheumatology, 25(3), 1998, pp. 441-446
Authors:
BAGGOTT JE
ROBINSON CB
ETO I
JOHANNING GL
CORNWELL PE
Citation: Je. Baggott et al., IRON COMPOUNDS CATALYZE THE OXIDATION OF 10-FORMYL-5,6,7,8-TETRAHYDROFOLIC ACID TO 10-FORMYL-7,8-DIHYDROFOLIC ACID, Journal of inorganic biochemistry, 71(3-4), 1998, pp. 181-187
Citation: Je. Baggott et al., THE EFFECT OF METHOTREXATE AND 7-HYDROXYMETHOTREXATE ON RAT ADJUVANT ARTHRITIS AND ON URINARY AMINOIMIDAZOLE CARBOXAMIDE EXCRETION, Arthritis and rheumatism, 41(8), 1998, pp. 1407-1410
Authors:
TAMURA T
BAGGOTT JE
JOHNSTON KE
LI QJ
ANTONY AC
Citation: T. Tamura et al., THE FORM OF FOLATE AFFECTS THE MECHANISMS OF METHOTREXATE RESISTANCE IN ENTEROCOCCUS-FAECIUM, Microbiology, 143, 1997, pp. 2639-2646
Authors:
BAGGOTT JE
JOHANNING GL
ETO I
ROBINSON CB
Citation: Je. Baggott et al., OXIDATION OF 10-FORMYL-TETRAHYDROFOLIC ACID (10-HCO-H(4)FOLATE) TO 10-FORMYL-7,8-DIHYDROFOLIC ACID (10-HCO-H(2)FOLATE) BY HYDROXY RADICAL (CENTER-DOT-OH) AND BY FERRICYTOCHROME-C (CYT-C-(III)), The FASEB journal, 11(3), 1997, pp. 1352-1352
Citation: Ma. Niemann et al., BINDING OF SPAAT, THE 44-RESIDUE C-TERMINAL PEPTIDE OF ALPHA-1-ANTITRYPSIN, TO PROTEINS OF THE EXTRACELLULAR-MATRIX, Journal of cellular biochemistry, 66(3), 1997, pp. 346-357
Citation: Ma. Niemann et al., INHIBITION OF HUMAN SERINE PROTEASES BY SPAAT, THE C-TERMINAL 44-RESIDUE PEPTIDE FROM ALPHA(1)-ANTITRYPSIN, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1340(1), 1997, pp. 123-130
Citation: Sl. Morgan et al., FOLIC-ACID PREVENTS ELEVATED HOMOCYSTEINE (HCY) LEVELS DURING METHOTREXATE (MTX) THERAPY, Arthritis and rheumatism, 40(9), 1997, pp. 138-138
Citation: T. Tamura et al., FORMS OF FOLATE REGULATE THE MECHANISMS OF METHOTREXATE RESISTANCE INSTREPTOCOCCUS-FAECIUM, The FASEB journal, 9(3), 1995, pp. 155-155
Authors:
CHATHAM WW
BAGGOTT JE
LOOSE LD
BLACKBURN WD
Citation: Ww. Chatham et al., EFFECTS OF TENIDAP ON SUPEROXIDE-GENERATING ENZYMES - NONCOMPETITIVE INHIBITION OF XANTHINE-OXIDASE, Biochemical pharmacology, 50(6), 1995, pp. 811-814
Citation: Ts. Ha et Je. Baggott, 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOTIDE (AICAR) AND ITS METABOLITES -METABOLIC AND CYTOTOXIC EFFECTS AND ACCUMULATION DURING METHOTREXATE TREATMENT, Journal of nutritional biochemistry, 5(11), 1994, pp. 522-528
Citation: Ts. Ha et Je. Baggott, 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOTIDE (AICAR) AND ITS METABOLITES -METABOLIC AND CYTOTOXIC EFFECTS AND ACCUMULATION DURING METHOTREXATE TREATMENT, Journal of nutritional biochemistry, 5(11), 1994, pp. 522-528
Citation: Je. Baggott et al., DIFFERENCES IN METHOTREXATE AND 7-HYDROXYMETHOTREXATE INHIBITION OF FOLATE-DEPENDENT ENZYMES OF PURINE NUCLEOTIDE BIOSYNTHESIS, Biochemical journal, 300, 1994, pp. 627-629
Authors:
MORGAN SL
BAGGOTT JE
ALARCON GS
KOOPMAN WJ
KRUMDIECK CL
Citation: Sl. Morgan et al., LEUCOVORIN VERSUS FOLIC-ACID IN THE TREATMENT OF METHOTREXATE TOXICITY - COMMENT ON THE ARTICLE BY SHIROKY ET-AL, Arthritis and rheumatism, 37(3), 1994, pp. 444-444
Authors:
MORGAN SL
BAGGOTT JE
VAUGHN WH
AUSTIN JS
VEITCH TA
LEE JY
KOOPMAN WJ
KRUMDIECK CL
ALARCON GS
Citation: Sl. Morgan et al., SUPPLEMENTATION WITH FOLIC-ACID DARING METHOTREXATE THERAPY FOR RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 121(11), 1994, pp. 833-841
Authors:
MORGAN SL
BAGGOTT JE
VAUGHN WH
AUSTIN JS
VEITCH TA
KRUMDIECK CL
KOOPMAN WJ
ALARCON GS
Citation: Sl. Morgan et al., 5 MG OR 50 MG WEEK OF FOLIC-ACID (FA) SUPPLEMENTATION DOES NOT ALTER THE EFFICACY OF METHOTREXATE (MTX)-TREATED RHEUMATOID-ARTHRITIS (RA) PATIENTS/, Arthritis and rheumatism, 36(9), 1993, pp. 190000079-190000079
Citation: Sl. Morgan et al., UNSUBSTANTIATED RISK OF ANTIFOLATE TOXICITY WITH COMBINATION METHOTREXATE AND SULFASALAZINE THERAPY - REPLY, Arthritis and rheumatism, 36(12), 1993, pp. 1757-1758